share_log

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-LONG FOCUS CAPITAL MANAGEMENT, LLC(5.3%),JOHN B. HELMERS(5.3%), etc.

SEC announcement ·  Feb 14 17:11
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more